Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Portola Pharmaceuticals to Webcast Presentation at Cowen and Company’s 39th Annual Health Care Conference
-
Portola Pharma (PTLA) Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
-
Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
-
Portola Pharmaceuticals (PTLA) PT Lowered to $45 at Cowen
-
Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Portola Pharmaceuticals (PTLA) PT Lowered to $65 at Cowen
-
Portola Pharma (PTLA) Prices 6.35M Share Offering at $55/Sh
-
Portola Announces Pricing of Public Offering of Common Stock
-
Portola Pharma (PTLA) to Offer $300M in Common Stock
-
Portola Pharmaceuticals Announces Proposed Offering of Common Stock
-
Portola Pharmaceuticals (PTLA) PT Raised to $45 at Cowen Following APEX & AndexXa Data Examination at Investor Event
-
Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Portola Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
-
Portola Announces Pricing of Public Offering of Common Stock
-
Portola Pharma (PTLA) Announces 2.6M Common Stock Offering
-
Portola Pharmaceuticals Announces Proposed Offering of Common Stock
-
Portola Pharmaceuticals (PTLA) PT Raised to $65 at Cowen
-
Portola Announces Pricing of Public Offering of Common Stock
-
Portola Pharmaceuticals to Present at the Cowen and Company 35th Annual Health Care Conference
-
Portola Pharma (PTLA) Prices 6.2M Common Offering at $26/Share
-
Portola Announces Pricing of Public Offering of Common Stock
-
Portola Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference
-
Portola Pharma (PTLA) Prices 6.37M Common Offering at $23.75/Share
-
Portola Pharma (PTLA) Announces $100M Common Stock Offering

